Tony Romo Injury Update: Cowboys' QB Expected To Play, Will Take Painkiller Injection

In case there was any doubt, Dallas Cowboys quarterback Tony Romo is expected to play in the Monday Night Football game against the Washington Redskins after suffering a rib injury last week. ESPN's Ed Werder reports that Romo will receive an injection to numb the pain in his broken rib. Via SBNation.com:

Romo's punctured lung has reportedly healed and dealing with the rib injury he has is generally a matter of pain tolerance. For that, ESPN's Ed Werder reports, Romo will take a painkiller injection for Monday's game and give it a go.

None of this is a surprise, since Romo himself said on Sunday that he would be "good to go" to play in the game. The Redskins will now just have to stop him and the Cowboys' first-string offense, save for wide receiver Miles Austin, who will miss the game.

For more on the Redskins vs. Cowboys Monday Night showdown, visit this StoryStream. Visit Hogs Haven for more on the Redskins, and visit Blogging the Boys and SB Nation Dallas for more on the Cowboys.

Trending Discussions

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

Join SB Nation DC

You must be a member of SB Nation DC to participate.

We have our own Community Guidelines at SB Nation DC. You should read them.

Join SB Nation DC

You must be a member of SB Nation DC to participate.

We have our own Community Guidelines at SB Nation DC. You should read them.

Spinner

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.